BMY Bristol-Myers Squibb Company
Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals | NYSE, LargeCap | Last Price: 62.37 | 2026-02-27 | Atrp: 2.08
Sat 21 Feb 2026 to Fri 27 Feb 2026: Score -2
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Percent | 1.47% | 1.56% | ▲ 6.12% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Price Sales TTM | 2.5632 | 2.6355 | ▲ 2.82% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Short Ratio | 2.42 | 2.35 | ▼ -2.89% | Bullish. Lower is better. Slight improvement |
Sat 14 Feb 2026 to Sat 21 Feb 2026: Score 3
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Return On Assets TTM | 9.39% | 10.29% | ▲ 9.58% | Bullish. Higher is better. Return on assets TTM growth accelerating. Efficiency in generating profits from total assets |
| â | Wall Street Target Price | 59.913 | 61.3333 | ▲ 2.37% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
Sat 07 Feb 2026 to Sat 14 Feb 2026: Score 5
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Percent | 1.82% | 1.47% | ▼ -19.23% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Enterprise Value/EBITDA | 11.0577 | 10.5162 | ▼ -4.9% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Forward PE | 10.352 | 9.9602 | ▼ -3.78% | Bullish. Lower is better. Slight improvement Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.6185 | 2.5666 | ▼ -1.98% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Institutional Ownership | 82.244% | 83.179% | ▲ 1.14% | Bullish. Higher is better. Slight increase; continued strong interest from big investors Percentage held by institutions like mutual funds |
| â | Short Ratio | 2.48 | 2.42 | ▼ -2.42% | Bullish. Lower is better. Slight improvement |
| â | Price Book MRQ | 5.3387 | 6.696 | ▲ 25.42% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
Fri 30 Jan 2026 to Sat 07 Feb 2026: Score 6
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Quarterly Earnings Growth YOY | 811% | 13941% | ▲ 1622.62% | Bullish. Higher is better. Quarterly earnings growth YOY growth accelerating. Year-over-year growth in quarterly earnings |
| â | Earnings Per Share | 2.97 | 3.46 | ▲ 16.5% | Bullish. Higher is better. Moderate increase in earnings per share Profit allocated to each outstanding share |
| â | Profit Margin | 12.57% | 14.64% | ▲ 16.47% | Bullish. Higher is better. Profit margin growth accelerating. Percentage of revenue that turns into profit |
| â | Return On Equity TTM | 33.78% | 40.33% | ▲ 19.39% | Bullish. Higher is better. Return on equity TTM growth accelerating. Efficiency in generating profits from shareholders' equity |
| â | Price Book MRQ | 5.9563 | 5.3387 | ▼ -10.37% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value | $145.04B | $160.74B | ▲ 10.82% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Wall Street Target Price | 58.0435 | 59.913 | ▲ 3.22% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | EPS Estimate Current Year | 6.1359 | 6.2122 | ▲ 1.24% | Bullish. Higher is better. Slight increase; improved outlook for current year earnings Expected earnings per share this year |
| â | Operating Margin TTM | 31.57% | 28.19% | ▼ -10.71% | Bearish. Higher is better. Operating margin TTM growth slowing. Percentage of revenue left after operating expenses |
| â | Forward PE | 9.0909 | 10.352 | ▲ 13.87% | Bearish. Lower is better. Moderate decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.3331 | 2.6185 | ▲ 12.23% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value/Revenue | 3.0195 | 3.3352 | ▲ 10.46% | Bearish. Lower is better. Moderate decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 9.7329 | 11.0577 | ▲ 13.61% | Bearish. Lower is better. Moderate decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Quarterly Revenue Growth YOY | 31% | 11% | ▼ -53.57% | Bearish. Higher is better. Quarterly revenue growth YOY growth slowing. Year-over-year growth in quarterly revenue |
Fri 23 Jan 2026 to Fri 30 Jan 2026: Score -2
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 2.25 | 2.48 | ▲ 10.22% | Bearish. Lower is better. Moderate decline |
| â | EPS Estimate Current Year | 6.3014 | 6.1359 | ▼ -2.63% | Bearish. Higher is better. Slight decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | Short Percent | 1.8% | 1.82% | ▲ 1.11% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Wall Street Target Price | 56.9565 | 58.0435 | ▲ 1.91% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Forward PE | 9.1996 | 9.0909 | ▼ -1.18% | Bullish. Lower is better. Slight improvement Stock price divided by expected future earnings |
| â | Price Book MRQ | 6.0287 | 5.9563 | ▼ -1.2% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
Fri 16 Jan 2026 to Fri 23 Jan 2026: Score 3
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Forward PE | 9.3545 | 9.1996 | ▼ -1.66% | Bullish. Lower is better. Slight improvement Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.342 | 2.3161 | ▼ -1.11% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 6.213 | 6.0287 | ▼ -2.97% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 3.1187 | 3.0475 | ▼ -2.28% | Bullish. Lower is better. Slight improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 10.0526 | 9.8231 | ▼ -2.28% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | EPS Estimate Current Year | 6.4358 | 6.3014 | ▼ -2.09% | Bearish. Higher is better. Slight decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | Enterprise Value | $149.8B | $146.38B | ▼ -2.28% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Fri 09 Jan 2026 to Fri 16 Jan 2026: Score -1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | EPS Estimate Current Year | 6.5342 | 6.4358 | ▼ -1.51% | Bearish. Higher is better. Slight decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | Forward PE | 9.2421 | 9.3545 | ▲ 1.22% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Book MRQ | 6.134 | 6.213 | ▲ 1.29% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Short Percent | 1.74% | 1.8% | ▲ 3.45% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Wall Street Target Price | 56.2609 | 56.9565 | ▲ 1.24% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Price Sales TTM | 2.3674 | 2.342 | ▼ -1.07% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Short Ratio | 2.29 | 2.25 | ▼ -1.75% | Bullish. Lower is better. Slight improvement |
Fri 02 Jan 2026 to Fri 09 Jan 2026: Score -4
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Price Sales TTM | 2.2657 | 2.3674 | ▲ 4.49% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Forward PE | 8.9127 | 9.2421 | ▲ 3.7% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Book MRQ | 5.919 | 6.134 | ▲ 3.63% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 3.0051 | 3.0882 | ▲ 2.77% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 9.6865 | 9.9542 | ▲ 2.76% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Wall Street Target Price | 55.087 | 56.2609 | ▲ 2.13% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Enterprise Value | $144.35B | $148.34B | ▲ 2.76% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sat 20 Dec 2025 to Fri 02 Jan 2026: Score -2
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 2.12 | 2.29 | ▲ 8.02% | Bearish. Lower is better. Slight decline |
| â | Short Percent | 1.67% | 1.74% | ▲ 4.19% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Wall Street Target Price | 54.5 | 55.087 | ▲ 1.08% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Price Sales TTM | 2.2967 | 2.2657 | ▼ -1.35% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |